Pleo Quent
FDA Label NDC 60681-2902

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Quent (NDC 60681-2902). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding indications, ingredients, inactive ingredients, tamper evident, dosage, warning, principal display panel - 20 capsules carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Indications

For temporary relief of congestion due to colds and minor respiratory infections.

Ingredients

1 capsule contains 330 mg Penicillium glabrum 4X.

Inactive Ingredients

Lactose, Capsule shells consist of Hypromellose (HPMC).

Tamper Evident

Do not use this product if imprinted inner blister pack is broken or if imprinted security strip on carton is torn.

Dosage

1–3 capsules daily, either before breakfast or at bedtime.

Warning

If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before taking this product.

Principal Display Panel - 20 Capsules Carton

Pleo™ Quent
CAPSULES 4X

Homeopathic
Decongestant Medicine

Indications: For temporary
relief of congestion due
to colds and minor
respiratory infections.

ORIGINAL ENDERLEIN

20 CAPSULES

Principal Display Panel (20 Capsules Carton)

Principal Display Panel (20 Capsules Carton)

* Please review the disclaimer below.